Ayr Wellness AYRWF
OTC AYRWF
$0.00 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Ayr Wellness Inc. (AYRWF) Research & Development (2019 - 2022)

Ayr Wellness' (AYRWF) quarterly Research & Development came in at $1.8 million in Q1 2022, up 144.46% year-over-year from $743558.0 in Q1 2021, and down 44.35% quarter-over-quarter from $3.3 million in Q4 2021.

Analysis

Ayr Wellness Inc. (AYRWF) Research & Development (2019 - 2022) Analysis & Trends

Ayr Wellness (AYRWF) has reported Research & Development for 4 consecutive years, with $1.8 million the latest figure, recorded in Q1 2022.

  • On a quarterly basis, Research & Development rose 144.46% year-over-year to $1.8 million in Q1 2022; TTM through Mar 2022 was $8.8 million, a 271.87% increase from a year earlier, with the FY2021 full-year figure at $7.7 million, up 258.05% from the prior year.
  • Research & Development was $1.8 million for Q1 2022 at Ayr Wellness, down from $3.3 million in the prior quarter.
  • Over five years, Research & Development peaked at $3.3 million in Q4 2021 and troughed at $409247.0 in Q2 2020.
  • A 4-year average of $1.2 million and a median of $693281.5 in 2020 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development gained 21.63% in 2020 and soared 479.5% in 2021, its largest moves.
  • Over 4 years, Research & Development stood at $463452.0 in 2019, then grew by 21.63% to $563687.0 in 2020, then soared by 479.5% to $3.3 million in 2021, then tumbled by 44.35% to $1.8 million in 2022.
  • The last three Research & Development figures came in at $1.8 million (Q1 2022), $3.3 million (Q4 2021), and $1.9 million (Q3 2021), per Business Quant data.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.82 Mn
Dec 31, 2021 3.27 Mn
Sep 30, 2021 1.92 Mn
Jun 30, 2021 1.77 Mn
Mar 31, 2021 743,558.00
Dec 31, 2020 563,687.00
Sep 30, 2020 643,005.00
Jun 30, 2020 409,247.00
Mar 31, 2020 534,598.00
Dec 31, 2019 463,452.00